Physical activity attenuates age-related biomarker alterations in preclinical AD

Neurology

Volumn 83, Issue 19, 2014, Pages 1753-1760

  Okonkwo, Ozioma C ^a,b   Schultz, Stephanie A ^a,b   Oh, Jennifer M ^a,b   Larson, Jordan ^a,b   Edwards, Dorothy ^b   Cook, Dane ^a,b   Koscik, Rebecca ^b   Gallagher, Catherine L ^a,b   Dowling, N M ^b   Carlsson, Cynthia M ^a,b   Bendlin, Barbara B ^a,b   LaRue, Asenath ^b   Rowley, Howard A ^b   Christian, Brad T ^b   Asthana, Sanjay ^a,b   Hermann, Bruce P ^b   Johnson, Sterling C ^a,b   Sager, Mark A ^b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; GLUCOSE; PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SELF REPORT; SHORT TERM MEMORY; UNITED STATES; VELOCITY; VERBAL MEMORY; WORKING MEMORY; AGE; AGED; ANATOMY AND HISTOLOGY; BRAIN; DIAGNOSTIC USE; GENETICS; LONGITUDINAL STUDY; METABOLISM; MOTOR ACTIVITY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; QUESTIONNAIRE; SCINTISCANNING; VISION;

ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APOLIPOPROTEIN E4; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; RISK FACTORS; THIAZOLES; VISUAL PERCEPTION;

EID: 84917700026     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000964     Document Type: Article

References (39)

1. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005;25: 4217-4221.
2. Fuss J, Biedermann SV, Falfan-Melgoza C, et al. Exercise boosts hippocampal volume by preventing early age-related gray matter loss. Hippocampus 2014;24: 131-134.
3. Marlatt MW, Potter MC, Lucassen PJ, van Praag H. Running throughout middle-age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice. Dev Neurobiol 2012;72:943-952.
4. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008; (3):CD005381.
5. Honea RA, Thomas GP, Harsha A, et al. Cardiorespira-tory fitness and preserved medial temporal lobe volume in Alzheimer disease. Alzheimer Dis Assoc Disord 2009;23: 188-197.
6. Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108: 3017-3022.
7. Erickson KI, Prakash RS, Voss MW, et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009;19:1030-1039.
8. Liang KY, Mintun MA, Fagan AM, et al. Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol 2010;68:311-318.
9. Head D, Bugg JM, Goate AM, et al. Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition. Arch Neurol 2012;69:636-643.
10. Brown BM, Peiffer JJ, Taddei K, et al. Physical activity and amyloid-beta plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Mol Psychiatry 2013;18:875-881.
11. Landau SM, Marks SM, Mormino EC, et al. Association of lifetime cognitive engagement and low beta-amyloid deposition. Arch Neurol 2012;69:623-629.
12. Vemuri P, Lesnick TG, Przybelski SA, et al. Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol 2012;72:730-738.
13. Bugg JM, Head D. Exercise moderates age-related atrophy of the medial temporal lobe. Neurobiol Aging 2011;32: 506-514.
14. Colcombe SJ, Erickson KI, Raz N, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003;58:176-180.
15. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-357.
16. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med 2009;360:2302-2309.
17. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-1359.
18. Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a006239.
19. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
20. Sager MA, Hermann B, La Rue A. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J Geriatr Psychiatry Neurol 2005;18:245-249.
21. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmen-opausal women: the Women's Health Initiative Cohort Study. JAMA 2003;290:1331-1336.
22. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39:1435-1445.
23. Johnson SC, Christian BT, Okonkwo OC, et al. Amyloid burden and neural function in people at risk for Alzheimer's disease. Neurobiol Aging 2014;35:576-584.
24. Jagust WJ, Bandy D, Chen K, et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 2010;6:221-229.
25. Floberg JM, Mistretta CA, Weichert JP, Hall LT, Holden JE, Christian BT. Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. Med Phys 2012;39:3319-3331.
26. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B. J Cereb Blood Flow Metab 2005;25:1528-1547.
27. Landau SM, Harvey D, Madison CM, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2011;32: 1207-1218.
28. Dowling NM, Hermann B, La Rue A, Sager MA. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease. Neuropsychology 2010;24:742-756.
29. Koscik RL, La Rue A, Jonaitis EM, et al. Emergence of mild cognitive impairment in late middle-aged adults in the Wisconsin Registry for Alzheimer's Prevention. Dement Geriatr Cogn Disord 2014;38:16-30.
30. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
31. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002;21: 2409-2419.
32. Okonkwo OC, Oh JM, Koscik R, et al. Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease. J Int Neuropsychol Soc 2014;20:422-433.
33. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011;10:819-828.
34. Pereira AC, Huddleston DE, Brickman AM, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA 2007;104: 5638-5643.
35. Burdette JH, Laurienti PJ, Espeland MA, et al. Using network science to evaluate exercise-associated brain changes in older adults. Front Aging Neurosci 2010;2:23.
36. Nelson PT, Smith CD, Abner EL, et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 2013;126:161-177.
37. DeCarolis NA, Eisch AJ. Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation. Neuropharmacology 2010;58:884-893.
38. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998; 55: 326-335.
39. Drachman DA. Aging of the brain, entropy, and Alzheimer disease. Neurology 2006;67:1340-1352.